2,3-diphosphoglycerate has been researched along with EHS Tumor in 1 studies
2,3-Diphosphoglycerate: A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase (EC 5.4.2.1). (From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508)
2,3-bisphosphoglyceric acid : A bisphosphoglyceric acid that is glyceric acid carrying two phospho substituents at positions 2 and 3.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siemann, DW | 1 |
| Alliet, KL | 1 |
| Macler, LM | 1 |
1 other study available for 2,3-diphosphoglycerate and EHS Tumor
| Article | Year |
|---|---|
Manipulations in the oxygen transport capacity of blood as a means of sensitizing tumors to radiation therapy.
Topics: 2,3-Diphosphoglycerate; Animals; Blood Preservation; Clofibrate; Diphosphoglyceric Acids; Erythrocyt | 1989 |